4-pregenen-11β-17-21-triol-3,20-dione derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 9, 2014
Issued Date -
N/A
app pub date -
Nov 9, 2012
filing date -
Nov 11, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to novel 4-pregenen-11β-17-21-triol-3,20-dione derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully